Crescendo Bioscience Secures $31,000,000 Series C Round

  • Feed Type
  • Date
    9/8/2011
  • Company Name
    Crescendo Bioscience
  • Mailing Address
    341 Oyster Point Blvd South San Francisco, CA 94080
  • Company Description
    Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.
  • Website
    http://www.crescendobio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $31,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The company will use the funding to accelerate commercialization of its Vectra DA diagnostic test and expand its pipeline of molecular diagnostic products for rheumatoid arthritis and other inflammatory diseases.
  • M&A Terms
  • Venture Investor
    Aeris Capital AG
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    Mohr Davidow Ventures

By posting a comment, you agree to our terms and conditions.